The detection of diseases at an early stage of development provides many benefits, such as timely and specific treatment with considerable cost savings and the ability to trace the cause of an illness. To support the progress of early diagnostics, VITO focuses on the development of diagnostic assays and technologies, and on the identification of new biomarkers. We do this in close collaboration with academic partners, health experts and the pharmaceutical and biotech industries.

Publications

Towards Building a Quantitative Proteomics Toolbox in Precision Medicine: A Mini-Review
Year: 
2021
Journal: 
FRONTIERS IN PHYSIOLOGY
Rojo, AC; Heylen, D; Aerts, J; Thas, O; Hooyberghs, J; Ertaylan, G; Valkenborg, D
Comparative retinal imaging in mouse models of proteinopathies identifies disease specific biomarkers
Year: 
2021
Journal: 
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
De Groef, L; Veys, L; Vandenabeele, M; Hadoux, X; Lemmens, S; Serneels, L; Theunis, J; De Strooper, B; Stalmans, I; van Wijngaarden, P; Moons, LKM
The effects of traveling in different transport modes on galvanic skin response (GSR) as a measure of stress: An observational study
Year: 
2021
Journal: 
ENVIRONMENT INTERNATIONAL
Yang, XL; McCoy, E; Anaya-Boig, E; Avila-Palencia, I; Brand, C; Carrasco-Turigas, G; Dons, E; Gerike, R; Goetschi, T; Nieuwenhuijsen, M; Orjuela, JP; Panis, LI; Standaert, A; de Nazelle, A
Collection and storage of human white blood cells for analysis of DNA damage and repair activity using the comet assay in molecular epidemiology studies
Year: 
2021
Journal: 
MUTAGENESIS
Moller, P; Bankoglu, EE; Stopper, H; Giovannelli, L; Ladeira, C; Koppen, G; Gajski, G; Collins, A; Valdiglesias, V; Laffon, B; Boutet-Robinet, E; Perdry, H; Del Bo', C; Langie, SAS; Dusinska, M; Azqueta, A

Pages